Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.
The neurobiological rationale for an opiate antagonist pharmacotherapy of autism is presented. Naltrexone efficacy in decreasing autistic behaviour and in increasing social-affiliative behaviour was explored
